These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25279503)

  • 1. Bioenergetic differences between MCF-7 and T47D breast cancer cells and their regulation by oestradiol and tamoxifen.
    Radde BN; Ivanova MM; Mai HX; Salabei JK; Hill BG; Klinge CM
    Biochem J; 2015 Jan; 465(1):49-61. PubMed ID: 25279503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear respiratory factor-1 and bioenergetics in tamoxifen-resistant breast cancer cells.
    Radde BN; Ivanova MM; Mai HX; Alizadeh-Rad N; Piell K; Van Hoose P; Cole MP; Muluhngwi P; Kalbfleisch TS; Rouchka EC; Hill BG; Klinge CM
    Exp Cell Res; 2016 Sep; 347(1):222-231. PubMed ID: 27515002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estradiol and tamoxifen regulate NRF-1 and mitochondrial function in mouse mammary gland and uterus.
    Ivanova MM; Radde BN; Son J; Mehta FF; Chung SH; Klinge CM
    J Mol Endocrinol; 2013 Oct; 51(2):233-46. PubMed ID: 23892277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anacardic Acid, Salicylic Acid, and Oleic Acid Differentially Alter Cellular Bioenergetic Function in Breast Cancer Cells.
    Radde BN; Alizadeh-Rad N; Price SM; Schultz DJ; Klinge CM
    J Cell Biochem; 2016 Nov; 117(11):2521-32. PubMed ID: 26990649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extranuclear ERα is associated with regression of T47D PKCα-overexpressing, tamoxifen-resistant breast cancer.
    Perez White B; Molloy ME; Zhao H; Zhang Y; Tonetti DA
    Mol Cancer; 2013 May; 12():34. PubMed ID: 23634843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of Estrogen Receptor β modulates the response of breast cancer cells to therapeutic agents.
    Pons DG; Torrens-Mas M; Nadal-Serrano M; Sastre-Serra J; Roca P; Oliver J
    Int J Biochem Cell Biol; 2015 Sep; 66():85-94. PubMed ID: 26232188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased chicken ovalbumin upstream promoter transcription factor II expression in tamoxifen-resistant breast cancer cells.
    Riggs KA; Wickramasinghe NS; Cochrum RK; Watts MB; Klinge CM
    Cancer Res; 2006 Oct; 66(20):10188-98. PubMed ID: 17047084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genistein modulates proliferation and mitochondrial functionality in breast cancer cells depending on ERalpha/ERbeta ratio.
    Pons DG; Nadal-Serrano M; Blanquer-Rossello MM; Sastre-Serra J; Oliver J; Roca P
    J Cell Biochem; 2014 May; 115(5):949-58. PubMed ID: 24375531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of gene regulation patterns underlying both oestrogen- and tamoxifen-stimulated cell growth through global gene expression profiling in breast cancer cells.
    Fan P; Cunliffe HE; Griffith OL; Agboke FA; Ramos P; Gray JW; Jordan VC
    Eur J Cancer; 2014 Nov; 50(16):2877-86. PubMed ID: 25212499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Metabolism as a Therapeutic Option for Tamoxifen-Resistant Breast Cancer Cells.
    Steifensand F; Gallwas J; Bauerschmitz G; Gründker C
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen increases nuclear respiratory factor 1 transcription by activating estrogen receptor beta and AP-1 recruitment to adjacent promoter binding sites.
    Ivanova MM; Luken KH; Zimmer AS; Lenzo FL; Smith RJ; Arteel MW; Kollenberg TJ; Mattingly KA; Klinge CM
    FASEB J; 2011 Apr; 25(4):1402-16. PubMed ID: 21233487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibitory effect of carbamazepine on proliferation of estrogen-dependent breast cancer cells].
    Meng QW; Zhao CH; Xi YH; Cai L; Sun LC; Sui GJ
    Ai Zheng; 2006 Aug; 25(8):967-73. PubMed ID: 16965676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the AKT/mTOR and erbB pathways by gefitinib, perifosine and analogs of gonadotropin-releasing hormone I and II to overcome tamoxifen resistance in breast cancer cells.
    Block M; Gründker C; Fister S; Kubin J; Wilkens L; Mueller MD; Hemmerlein B; Emons G; Günthert AR
    Int J Oncol; 2012 Nov; 41(5):1845-54. PubMed ID: 22922893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of prolonged hydroxytamoxifen treatment of MCF-7 cells on mitogen activated kinase cascade.
    Rabenoelina F; Semlali A; Duchesne MJ; Freiss G; Pons M; Badia E
    Int J Cancer; 2002 Apr; 98(5):698-706. PubMed ID: 11920638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quercetin reverses tamoxifen resistance in breast cancer cells.
    Wang H; Tao L; Qi K; Zhang H; Feng D; Wei W; Kong H; Chen T; Lin Q
    J BUON; 2015; 20(3):707-13. PubMed ID: 26214621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions.
    Murphy CS; Pink JJ; Jordan VC
    Cancer Res; 1990 Nov; 50(22):7285-92. PubMed ID: 2224859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.
    Fleming FJ; Hill AD; McDermott EW; O'Higgins NJ; Young LS
    J Clin Endocrinol Metab; 2004 Jan; 89(1):375-83. PubMed ID: 14715875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation of Anti-miR-21 and 4-Hydroxytamoxifen Co-loaded Biodegradable Polymer Nanoparticles and Their Antiproliferative Effect on Breast Cancer Cells.
    Devulapally R; Sekar TV; Paulmurugan R
    Mol Pharm; 2015 Jun; 12(6):2080-92. PubMed ID: 25880495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulatory effect of oestradiol-17 beta and tamoxifen on gross cystic disease fluid protein 15,000 production and mRNA levels in T47D human breast cancer cells.
    Dejardin L; Gol-Winkler R; Collette J; Delvenne C; Carlisi I; Haagensen DE; Franchimont P
    J Mol Endocrinol; 1991 Oct; 7(2):105-12. PubMed ID: 1930624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulation of estrogen induced telomerase activity in tamoxifen-resistant breast cancer cells.
    Park WC; Liu H; Macgregor Schafer J; Jordan VC
    Int J Oncol; 2005 Nov; 27(5):1459-66. PubMed ID: 16211243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.